Bortezomib powder 1.0 mg/kg administrated weekly for 4 weeks reduces tumor growth by 60% in murine xenograft models of prostate cancer.
Bortezomib Pulver 1.0 mg / kg bewäerten wöchentlech fir 4 Wochen reduzéiert den Tumorwachstum duerch 60% an murine Xenograft Modelle vu Prostatakarque.